PubMed:32198291 / 475-644 JSONTXT

{"project":"LitCovid-OGER","denotations":[{"id":"T4","span":{"begin":44,"end":53},"obj":"CHEBI:35222"},{"id":"T5","span":{"begin":73,"end":78},"obj":"CHEBI:32988;CHEBI:29337"},{"id":"T6","span":{"begin":104,"end":112},"obj":"CHEBI:38183"},{"id":"T2","span":{"begin":121,"end":128},"obj":"SO:0000165"},{"id":"T1","span":{"begin":138,"end":142},"obj":"UBERON:0000104"}],"namespaces":[{"prefix":"PR","uri":"http://purl.obolibrary.org/obo/PR_"},{"prefix":"UBERON","uri":"http://purl.obolibrary.org/obo/UBERON_"}],"text":"This was derived from a previously designed inhibitor but with the P3-P2 amide bond incorporated into a pyridone ring to enhance the half-life of the compound in plasma."}

{"project":"LitCovid-sentences-v1","denotations":[{"id":"TextSentencer_T5","span":{"begin":0,"end":169},"obj":"Sentence"}],"text":"This was derived from a previously designed inhibitor but with the P3-P2 amide bond incorporated into a pyridone ring to enhance the half-life of the compound in plasma."}

{"project":"LitCovid-TimeML","denotations":[{"id":"tok86","span":{"begin":0,"end":4},"obj":"DT"},{"id":"tok87","span":{"begin":5,"end":8},"obj":"VBD"},{"id":"tok88","span":{"begin":9,"end":16},"obj":"VBN"},{"id":"tok89","span":{"begin":17,"end":21},"obj":"IN"},{"id":"tok90","span":{"begin":22,"end":23},"obj":"DT"},{"id":"tok91","span":{"begin":24,"end":34},"obj":"RB"},{"id":"tok92","span":{"begin":35,"end":43},"obj":"VBN"},{"id":"tok93","span":{"begin":44,"end":53},"obj":"NN"},{"id":"tok94","span":{"begin":54,"end":57},"obj":"CC"},{"id":"tok95","span":{"begin":58,"end":62},"obj":"IN"},{"id":"tok96","span":{"begin":63,"end":66},"obj":"DT"},{"id":"tok97","span":{"begin":67,"end":68},"obj":"NN"},{"id":"tok98","span":{"begin":68,"end":69},"obj":"CD"},{"id":"tok99","span":{"begin":69,"end":70},"obj":":"},{"id":"tok100","span":{"begin":70,"end":71},"obj":"NN"},{"id":"tok101","span":{"begin":71,"end":72},"obj":"CD"},{"id":"tok102","span":{"begin":73,"end":78},"obj":"NN"},{"id":"tok103","span":{"begin":79,"end":83},"obj":"NN"},{"id":"tok104","span":{"begin":84,"end":96},"obj":"VBN"},{"id":"tok105","span":{"begin":97,"end":101},"obj":"IN"},{"id":"tok106","span":{"begin":102,"end":103},"obj":"DT"},{"id":"tok107","span":{"begin":104,"end":112},"obj":"NN"},{"id":"tok108","span":{"begin":113,"end":117},"obj":"NN"},{"id":"tok109","span":{"begin":118,"end":120},"obj":"TO"},{"id":"tok110","span":{"begin":121,"end":128},"obj":"VB"},{"id":"tok111","span":{"begin":129,"end":132},"obj":"DT"},{"id":"tok112","span":{"begin":133,"end":142},"obj":"NN"},{"id":"tok113","span":{"begin":143,"end":145},"obj":"IN"},{"id":"tok114","span":{"begin":146,"end":149},"obj":"DT"},{"id":"tok115","span":{"begin":150,"end":158},"obj":"NN"},{"id":"tok116","span":{"begin":159,"end":161},"obj":"IN"},{"id":"tok117","span":{"begin":162,"end":168},"obj":"NN"},{"id":"tok118","span":{"begin":168,"end":169},"obj":"."},{"id":"lookup9","span":{"begin":0,"end":4},"obj":"time_modifier"},{"id":"lookup10","span":{"begin":118,"end":120},"obj":"country_code"},{"id":"lookup11","span":{"begin":133,"end":137},"obj":"date_unit"},{"id":"lookup12","span":{"begin":159,"end":161},"obj":"country_code"},{"id":"event2","span":{"begin":121,"end":128},"obj":"OCCURRENCE"},{"id":"event4","span":{"begin":9,"end":16},"obj":"OCCURRENCE"},{"id":"event6","span":{"begin":84,"end":96},"obj":"OCCURRENCE"}],"text":"This was derived from a previously designed inhibitor but with the P3-P2 amide bond incorporated into a pyridone ring to enhance the half-life of the compound in plasma."}

{"project":"LitCovid-PD-FMA-UBERON-v1","denotations":[{"id":"T2","span":{"begin":162,"end":168},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma62970"}],"text":"This was derived from a previously designed inhibitor but with the P3-P2 amide bond incorporated into a pyridone ring to enhance the half-life of the compound in plasma."}

{"project":"LitCovid-OGER-BB","denotations":[{"id":"T22","span":{"begin":44,"end":53},"obj":"CHEBI:35222"},{"id":"T23","span":{"begin":44,"end":53},"obj":"CHEBI:35222"},{"id":"T24","span":{"begin":73,"end":78},"obj":"CHEBI:29337"},{"id":"T25","span":{"begin":73,"end":78},"obj":"CHEBI:29337"},{"id":"T26","span":{"begin":104,"end":112},"obj":"CHEBI:38183"},{"id":"T27","span":{"begin":104,"end":112},"obj":"CHEBI:38183"},{"id":"T28","span":{"begin":150,"end":158},"obj":"CHEBI:36357"},{"id":"T29","span":{"begin":150,"end":158},"obj":"CHEBI:36357"},{"id":"T30","span":{"begin":162,"end":168},"obj":"UBERON:0001969"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"This was derived from a previously designed inhibitor but with the P3-P2 amide bond incorporated into a pyridone ring to enhance the half-life of the compound in plasma."}

{"project":"LitCovid_AGAC","denotations":[{"id":"p116819s24","span":{"begin":133,"end":142},"obj":"MPA"}],"text":"This was derived from a previously designed inhibitor but with the P3-P2 amide bond incorporated into a pyridone ring to enhance the half-life of the compound in plasma."}